Complete functional rescue of the ABCA1−/− mouse by human BAC transgenesis Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M400506-JLR200
暂无分享,去创建一个
David J. Arenillas | M. Hayden | W. Wasserman | B. Staels | J. Fruchart | C. Fiévet | N. Bissada | R. Singaraja | Ann M. Joseph-George | Martin H. Kang | Jonathan M Coutinho | L. Bertram
[1] M. Hayden,et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.
[2] A. Sandelin,et al. Prediction of nuclear hormone receptor response elements. , 2005, Molecular endocrinology.
[3] Liang Chen,et al. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor Published, JLR Papers in Press, August 1, 2004. DOI 10.1194/jlr.M400257-JLR200 , 2004, Journal of Lipid Research.
[4] I. Yanai,et al. Incongruent expression profiles between human and mouse orthologous genes suggest widespread neutral evolution of transcription control. , 2004, Omics : a journal of integrative biology.
[5] Wyeth W. Wasserman,et al. ConSite: web-based prediction of regulatory elements using cross-species comparison , 2004, Nucleic Acids Res..
[6] J. Ward,et al. Diminished Hepatocellular Proliferation in Mice Humanized for the Nuclear Receptor Peroxisome Proliferator-Activated Receptor α , 2004, Cancer Research.
[7] Michel Koenig,et al. Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice , 2004, Mammalian Genome.
[8] A. Sandelin,et al. Applied bioinformatics for the identification of regulatory elements , 2004, Nature Reviews Genetics.
[9] Francesca Chiaromonte,et al. Regulatory potential scores from genome-wide three-way alignments of human, mouse, and rat. , 2004, Genome research.
[10] A. Tall,et al. Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jlr.M300432-JLR200 , 2004, Journal of Lipid Research.
[11] M. Hayden,et al. Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1 Published, JLR Papers in Press, May 1, 2003. DOI 10.1194/jlr.M300110-JLR200 , 2003, Journal of Lipid Research.
[12] H. Brewer,et al. Study of ABCA1 function in transgenic mice. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[13] A. Sandelin,et al. Identification of conserved regulatory elements by comparative genome analysis , 2003, Journal of biology.
[14] C. Tohyama,et al. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Rader,et al. Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[16] H. Brewer,et al. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.M200414-JLR200 , 2003, Journal of Lipid Research.
[17] S. Goodart,et al. Mice Expressing the Human CYP7A1 Gene in the Mouse CYP7A1 Knock-out Background Lack Induction of CYP7A1 Expression by Cholesterol Feeding and Have Increased Hypercholesterolemia When Fed a High Fat Diet* , 2002, The Journal of Biological Chemistry.
[18] Folkert Kuipers,et al. Stimulation of Lipogenesis by Pharmacological Activation of the Liver X Receptor Leads to Production of Large, Triglyceride-rich Very Low Density Lipoprotein Particles* , 2002, The Journal of Biological Chemistry.
[19] Sridhar Hannenhalli,et al. Identification of transcription factor binding sites in the human genome sequence , 2002, Mammalian Genome.
[20] B. McManus,et al. Increased ABCA1 activity protects against atherosclerosis. , 2002, The Journal of clinical investigation.
[21] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[22] W. Fung-Leung,et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. Snaith,et al. Transgenic systems in drug discovery: from target identification to humanized mice. , 2002, Drug discovery today.
[24] O. Francone,et al. Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[25] J. Oram,et al. Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1. , 2002, Trends in molecular medicine.
[26] B. McManus,et al. ABCA1 mRNA and Protein Distribution Patterns Predict Multiple Different Roles and Levels of Regulation , 2002, Laboratory Investigation.
[27] R. F. Hoyt,et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] O. Francone,et al. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. , 2001, The Journal of clinical investigation.
[29] M. Hayden,et al. Human ABCA1 BAC Transgenic Mice Show Increased High Density Lipoprotein Cholesterol and ApoAI-dependent Efflux Stimulated by an Internal Promoter Containing Liver X Receptor Response Elements in Intron 1* , 2001, The Journal of Biological Chemistry.
[30] H. Brewer,et al. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. , 2001, The Journal of clinical investigation.
[31] A. Tall,et al. ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein* , 2001, The Journal of Biological Chemistry.
[32] J. Cheng,et al. Regulation and Activity of the Human ABCA1 Gene in Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[33] J. Cheng,et al. Human and mouse ABCA1 comparative sequencing and transgenesis studies revealing novel regulatory sequences. , 2001, Genomics.
[34] T. Langmann,et al. Structure, function and regulation of the ABC1 gene product , 2001, Current opinion in lipidology.
[35] M. Hayden,et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. , 2000, The Journal of clinical investigation.
[36] C. Lawrence,et al. Human-mouse genome comparisons to locate regulatory sites , 2000, Nature Genetics.
[37] A. Tall,et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. , 2000, The Journal of biological chemistry.
[38] J. Cheng,et al. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] C. Gabel,et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Hayden,et al. Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency , 2000, Current opinion in lipidology.
[41] A. Attie,et al. The role of the LDL receptor in apolipoprotein B secretion. , 2000, The Journal of clinical investigation.
[42] A. Wagner,et al. Decoupled evolution of coding region and mRNA expression patterns after gene duplication: implications for the neutralist-selectionist debate. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[43] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[44] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[45] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[46] T. Langmann,et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.
[47] A Rubartelli,et al. Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. , 1997, Blood.
[48] D. Mangelsdorf,et al. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. , 1997, Genes & development.
[49] M. Luciani,et al. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. , 1996, The EMBO journal.
[50] K. Umesono,et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.
[51] C. Fielding,et al. Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.
[52] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[53] P. Linsel-Nitschke,et al. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. , 2003, The Journal of clinical investigation.
[54] C. Carlberg,et al. Differential nuclear receptor signalling from DR4‐type response elements , 2002, Journal of cellular biochemistry.